HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Key West Bans Purported Coral-Killing Sunscreens, With Florida-Wide Proposal Now On The Table

Executive Summary

The City Commission voted 6-1 at its Feb. 5 meeting to prohibit the sale of sunscreens formulated with oxybenzone and/or octinoxate beginning Jan. 1, 2021. That same day, Florida state Senator Linda Stewart proposed similar legislation that would push the effective date up to July 1, 2019, also citing the ingredients’ suspected role in coral declines.

You may also be interested in...



Beauty Market News: China Cosmetics Regulations Modernized, Florida Stops Local Oxybenzone Bans, More

L’Oreal acquires Thayers Natural Remedies; Unilever, L’Oreal remove ‘whitening,’ ‘fair’ from labels; China finalizes modernization of cosmetics regulations; and Florida governor signs law preventing local bans on oxybenzone.

Florida Preemption Bill Poised To Undo Key West Sunscreen Ban

Headed for its second reading in the Florida House after its counterpart passed the Senate on 29 January, HB 113 would expressly preempt local regulation of OTC drugs and cosmetics. According to House analysis documents, “This nullifies the current City of Key West ordinance” banning the sale of sunscreens containing reputed coral-killing UV filters.

Oxybenzone Sunscreen Remains Live Issue As Florida Lawmakers Lay Groundwork For 2020

Florida's legislature does not reconvene until mid-January 2020, but interim committee meetings are in progress and a proposed bill to ban non-prescription sales of oxybenzone/octinoxate-containing sunscreens already has been filed for consideration in the next session.

Related Content

Topics

UsernamePublicRestriction

Register

LL1128165

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel